Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,156 followers.

RT @FrontImmunol: New Research: Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant: Vaccine adjuvants from natural resources have been…

Reply Repost Favourite

Muito importante os avanços no campo de adjuvantes

Reply Repost Favourite

New Research: Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant: Vaccine adjuvants from natural resources have been utilized for enhancing vaccine efficacy against infectious diseases. This study examined the potential use of catechins,… https://t.co/

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.